Malaria vaccine trials on humans said to be ‘very promising’

The results of the first human trials of a malaria vaccine developed by Irish and British scientists are described as very promising.

The vaccine was developed by researchers at the Royal College of Surgeons in Ireland in collaboration with Oxford University. During the trials, which was funded by the European Vaccine Initiative, 24 volunteers were exposed to malaria after vaccination to assess its effectiveness.

The vaccine has been found to be safe and well-tolerated and the immunology results are very promising. The test results were released ahead of World Malaria Day today and the vaccine will now progress to more advanced trials at Oxford.